SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-23-002551
Filing Date
2023-07-25
Accepted
2023-07-25 12:09:13
Documents
13
Period of Report
2023-07-25

Document Format Files

Seq Description Document Type Size
1 6-K zk2330024.htm 6-K 13076
2 EXHIBIT 1.1 exhibit_1-1.htm EX-99 194687
3 EXHIBIT 1.2 exhibit_1-2.htm EX-99 83355
4 EXHIBIT 1.3 exhibit_1-3.htm EX-99 102574
5 EXHIBIT 1.4 exhibit_1-4.htm EX-99 51518
6 EXHIBIT 1.5 exhibit_1-5.htm EX-99 102537
7 EXHIBIT 1.6 exhibit_1-6.htm EX-99 102635
8 EXHIBIT 5.1 exhibit_5-1.htm EX-99 10041
9 EXHIBIT 5.2 exhibit_5-2.htm EX-99 15305
10 image00003.jpg GRAPHIC 15472
11 image00004.jpg GRAPHIC 12772
12 image00006.jpg GRAPHIC 53237
13 img01.jpg GRAPHIC 6847
  Complete submission text file 0001178913-23-002551.txt   798788
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 231107561
SIC: 2834 Pharmaceutical Preparations